Get started
Author

Renske Hesselink

Observed name: Hesselink, Renske
ORCID: 0000-0001-7447-4434
Observed ORCID: 0000-0001-7447-4434
OpenAlex ID: A5035701142
Improving vaccine equity by increasing vaccine thermostability
2024 · Jonathan Hare, Renske Hesselink, et al. · Science Translational Medicine · 15
Accelerating the development of vaccine microarray patches for epidemic response and equitable immunization coverage requires investment in microarray patch manufacturing facilities
2023 · Tiziana Scarnà, Marion Menozzi-Arnaud, et al. · Expert Opinion on Drug Delivery · 13
PDF
Stability Preparedness: The Not-So-Cold Case for Innovations in Vaccine Stability Modelling and Product Release
2024 · Franz Schnetzinger, Didier Clénet, et al. · Vaccines · 12
Lessons from the pandemic: Responding to emerging zoonotic viral diseases—a Keystone Symposia report
2022 · Jennifer Cable, Anthony Fauci, et al. · Annals of the New York Academy of Sciences · 12
A Strategic Guide to Improve and De-Risk Vaccine Development: CEPI’s CMC Framework
2024 · Anna Särnefält, Ranna Eardley-Patel, et al. · PDA Journal of Pharmaceutical Science and Technology · 5
Second regulatory workshop on utilising in silico models to expedite vaccine development, testing, and lifecycle management - an expert meeting report
2026 · Irina Meln, Wim Van Molle, et al. · Vaccine
Second regulatory workshop on utilising in silico models to expedite vaccine development, testing, and lifecycle management - an expert meeting report
2026 · Meln, Irina, Van Molle, Wim, et al. · Vaccine
Works count: 7
Citation count: 57
H-index: 5
I10-index: 4
Year
Topic
Type